| Original language | English (US) |
|---|---|
| Pages (from-to) | e288-e292 |
| Journal | Haematologica |
| Volume | 103 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 3 2018 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Haematologica, Vol. 103, No. 7, 03.07.2018, p. e288-e292.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the medical research council UK acute lymphoblastic leukemia 2003 trial
AU - Farah, Nadine
AU - Kirkwood, Amy A.
AU - Rahman, Sunniyat
AU - Leon, Theresa
AU - Jenkinson, Sarah
AU - Gale, Rosemary E.
AU - Patrick, Katharine
AU - Hancock, Jeremy
AU - Samarasinghe, Sujith
AU - Linch, David C.
AU - Moorman, Anthony V.
AU - Goulden, Nicholas
AU - Vora, Ajay
AU - Mansour, Marc R.
N1 - Funding Information: 1Department of Haematology, UCL Cancer Institute, London; 2Cancer Research UK & UCL Cancer Trials Centre, UCL, London; 3Department of Haematology, Sheffield Children’s Hospital; 4Bristol Genetics Laboratory, Southmead Hospital; 5Department of Haematology, Great Ormond Street Hospital and 6Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle, UK Correspondence: m.mansour@ucl.ac.uk doi:10.3324/haematol.2017.185801 Acknowledgements: the authors would like to thank Great Ormond Street Hospital Children’s Charity, Cancer Research UK and Bloodwise charities for funding and supporting this work. Funding Information: The authors would like to thank Great Ormond Street Hospital Children’s Charity, Cancer Research UK and Bloodwise charities for funding and supporting this work. this work was undertaken at UCL which receives a proportion of funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme. Primary childhood leukemia samples used in the study were provided by the Bloodwise Childhood Leukaemia Cell Bank. The trial was funded by the UK MRC and Leukaemia and Lymphoma Research (now Bloodwise). The authors are grateful to all the hospital centers, clinical staff and patients who participated in the UKALL2003 trial. Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org. Funding Information: Funding: this work was undertaken at UCL which receives a proportion of funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme. Primary childhood leukemia samples used in the study were provided by the Bloodwise Childhood Leukaemia Cell Bank. The trial was funded by the UK MRC and Leukaemia and Lymphoma Research (now Bloodwise). The authors are grateful to all the hospital centers, clinical staff and patients who participated in the UKALL2003 trial.
PY - 2018/7/3
Y1 - 2018/7/3
UR - http://www.scopus.com/inward/record.url?scp=85049582982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049582982&partnerID=8YFLogxK
U2 - 10.3324/haematol.2017.185801
DO - 10.3324/haematol.2017.185801
M3 - Letter
C2 - 29519867
AN - SCOPUS:85049582982
SN - 0390-6078
VL - 103
SP - e288-e292
JO - Haematologica
JF - Haematologica
IS - 7
ER -